1.Polypoid Amelanotic Melanoma on the Thigh.
Heung Yeol KIM ; Sae Bo Mi PARK ; Eun Ju PARK ; In Ho KWON ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2012;50(8):710-713
Amelanotic maliganat melanoma is a comparatively rare disease. It accounts for 1.8~8.1% of all malignant melanoma. It is sometime difficult to diagnose amelanotic malignant melanoma because there is no pigmentation, clinically. Polypoid melanoma is a variant of nodular melanoma, which in depth seldom reaches the reticular dermis. The main part of the tumor is located above the nearby epidermis, raised in the form resembling cauliflower. We report a rare case of amelanotic malignant melanoma with polypoid feature in a 78-year-old woman who presented a single bright red nodule on the left thigh.
Aged
;
Brassica
;
Dermis
;
Epidermis
;
Female
;
Humans
;
Melanoma
;
Melanoma, Amelanotic
;
Pigmentation
;
Rare Diseases
;
Thigh
2.Association of the Polymorphisms in the PSMA6 (rs1048990) and PSMB5 (rs2230087) Genes with Type 2 Diabetes in Korean Subjects.
Hee Kyoung KIM ; Su Won KIM ; Yun Jeong DOH ; Sae Rom KIM ; Mi Kyung KIM ; Keun Gyu PARK ; Hye Soon KIM ; Kyong Soo PARK ; Min YOO ; Jung Guk KIM ; Bo Wan KIM ; In Kyu LEE
Korean Diabetes Journal 2008;32(3):204-214
BACKGROUND: The 26S ubiquitin-proteasome system (UPS) is a principal proteolytic pathway of intracellular molecules regulating apoptosis, cell cycle, cell proliferation or differentiation, inflammation and etc. The recent study suggests that the rs1048990 (C/G) polymorphism of the proteasome subunit alpha type 6 (PSMA6) gene is associated with the increase of the risk of myocardial infarction by the dysregulation of IkappaB degradation. We hypothesized that 26S UPS is important in the development of insulin resistance and type 2 diabetes (T2DM) by controlling the degradation of IkappaB and insulin receptor substances as a substrate. We therefore investigated whether the rs1048990 (C/G) polymorphism of PSMA6 gene and the rs2230087 (G/A) polymorphism of proteasome subunit beta type 5 gene (PSMB5), that is chymotrypsin-like protease determining the rate of proteolysis, are associated with susceptibility to T2DM in Korean subjects. METHODS: We examined the polymorphisms of these genes in 309 diabetic subjects and 170 non-diabetic controls. The polymorphisms of rs1048990 (C/G) and rs2230087 (G/A) were genotyped by real-time PCR. RESULTS: The frequency of the G allele of rs1048990 (C/G) and the A allele of rs2230087 (G/A) polymorphisms was significantly higher in diabetic patients (28% and 13%) compared to that in controls (13% and 1%; P = 0.000 and P = 0.000, respectively). Logistic regression analysis of the rs1048990 (C/G) polymorphism showed that the odds ratio (OR) (adjusted for age, smoking, waist circumference, fasting plasma glucose, systolic blood pressure, HDL-C, triglyceride, and total cholesterol) was 3.93 (95% confidence interval [CI], 2.35-6.59; P = 0.000) for the G allele and 5.09 (95% CI, 2.71-9.57; P = 0.000) for CG and GG genotype when compared with the CC genotype. Logistic regression analysis of the rs2230087 (G/A) polymorphism showed that the adjusted OR was 5.70 (95% CI, 1.63-19.98; P = 0.007) for the A allele and 6.08 (95% CI, 1.66-22.29; P = 0.006) for GA and AA genotype when compared with the GG genotype. In multiple logistic regression analysis with T2DM as the independent Variable rs1048990 (C/G) and rs2230087 (G/A) polymorphisms were the predictor for T2DM. CONCLUSION: We suggest that the G allele of rs1048990 (C/G) polymorphism and the A allele of rs2230087 (G/A) polymorphism may be genetic risk factor to type 2 diabetes mellitus in Korean subjects.
Alleles
;
Apoptosis
;
Blood Pressure
;
Cell Cycle
;
Cell Proliferation
;
Chymases
;
Diabetes Mellitus, Type 2
;
Fasting
;
Genotype
;
Glucose
;
Humans
;
Inflammation
;
Insulin Resistance
;
Logistic Models
;
Myocardial Infarction
;
Odds Ratio
;
Plasma
;
Proteasome Endopeptidase Complex
;
Proteolysis
;
Receptor, Insulin
;
Risk Factors
;
Smoke
;
Smoking
;
Waist Circumference
3.Relationship between 25-Hydroxyvitamin D Levels and Liver Fibrosis as Assessed by Transient Elastography in Patients with Chronic Liver Disease.
Bong Jin KO ; Young Seok KIM ; Sang Gyune KIM ; Jung Hwan PARK ; Sae Hwan LEE ; Soung Won JEONG ; Jae Young JANG ; Hong Soo KIM ; Boo Sung KIM ; Sun Mi KIM ; Young Don KIM ; Gab Jin CHEON ; Bo Ra LEE
Gut and Liver 2016;10(5):818-825
BACKGROUND/AIMS: Deficiencies of 25-hydroxyvitamin D (25(OH)D) are prevalent in patients with chronic liver disease (CLD). Liver fibrosis is the main determinant of CLD prognosis. The present study was performed to evaluate the correlation between 25(OH)D levels and liver fibrosis as assessed by transient elastography (TE) in patients with compensated CLD. METHODS: Serum 25(OH)D levels and liver stiffness were determined in a total of 207 patients who were subjected to the following exclusion criteria: patients with decompensated CLD; patients who had malignancies; patients who were taking medications; and patients who were pregnant. RESULTS: The most common etiology was chronic hepatitis B (53.1%). Advanced liver fibrosis (defined by TE [≥9.5 kPa]) was present in 75 patients (36.2%). There was a significant correlation between 25(OH)D deficiency and liver stiffness. Based on the multivariate analysis, the following factors were independently associated with advanced liver fibrosis: 25(OH)D deficiency (odds ratio [OR], 3.46; p=0.004), diabetes mellitus (OR, 3.04; p=0.041), and fibrosis-4 index (OR, 2.01; p<0.001). CONCLUSIONS: Patients with compensated CLD exhibit a close correlation between vitamin D level and liver stiffness as assessed by TE. Vitamin D deficiency was independently associated with advanced liver fibrosis.
Diabetes Mellitus
;
Elasticity Imaging Techniques*
;
Hepatitis B, Chronic
;
Humans
;
Liver Cirrhosis*
;
Liver Diseases*
;
Liver*
;
Multivariate Analysis
;
Prognosis
;
Vitamin D
;
Vitamin D Deficiency